Filing Flows › Comparisons › IOVA vs TWST
Iovance Biotherapeutics vs Twist Bioscience: IOVA and TWST compared
Iovance Biotherapeutics is the larger company: $121M of revenue in its latest quarter (Q3 2026) against $118M for Twist Bioscience (Q3 FY26). Iovance Biotherapeutics is growing faster (+80% against +23% a year earlier). Iovance Biotherapeutics is more profitable, with an operating margin of -19.7% against -30.6%.
Where the money goes: IOVA and TWST
Iovance Biotherapeutics (IOVA) · Q3 2026
Iovance Biotherapeutics, Q3 2026: revenue $121M (+80% year over year), operating margin -19.7%, net loss $22.3M, operating cash flow −$4.5M. The chart follows the revenue to costs, profit and cash.
Twist Bioscience (TWST) · Q3 FY26
Twist Bioscience, Q3 FY26: revenue $118M (+23% year over year), operating margin -30.6%, net loss $35.1M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
| Iovance Biotherapeutics (IOVA) | Twist Bioscience (TWST) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 FY26 |
| Revenue | $121M | $118M |
| Revenue growth, Y/Y | +80% | +23% |
| Operating margin | -19.7% | -30.6% |
| Net earnings | −$22.3M | −$35.1M |
| Net margin | -18.3% | -29.6% |
| Operating cash flow | −$4.5M | $1.1M |
| Market value | $6.6B | $10.0B |
| Analysts’ mean target | $14.50 | $168.25 |
Where the revenue comes from
Twist Bioscience
- NGS applications: $61.8M (52%)
- DNA synthesis and protein solutions: $56.6M (48%)
Questions
Which is bigger, Iovance Biotherapeutics or Twist Bioscience?
Iovance Biotherapeutics is the larger company: $121M of revenue in its latest quarter (Q3 2026) against $118M for Twist Bioscience (Q3 FY26).
Is Iovance Biotherapeutics or Twist Bioscience growing faster?
Iovance Biotherapeutics is growing faster (+80% against +23% a year earlier).
Which is more profitable, Iovance Biotherapeutics or Twist Bioscience?
Iovance Biotherapeutics is more profitable, with an operating margin of -19.7% against -30.6%.
More: Iovance Biotherapeutics earnings · how Iovance Biotherapeutics makes money · Twist Bioscience earnings · how Twist Bioscience makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 3, 2026). Fiscal quarters can end on different dates. Not investment advice.